PALO ALTO, Calif. / Nov 01, 2024 / Business Wire / Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.
● |
| Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA |
|
| Fireside chat on Tuesday, November 12 at 10:30 a.m. Eastern Time |
|
|
|
● |
| Wolfe Healthcare Conference in New York, NY |
|
| Hosting 1x1 meetings on Tuesday, November 19 |
|
|
|
● |
| Jefferies London Healthcare Conference 2024 in London, UK |
|
| Presentation on Wednesday, November 20 at 7:30 a.m. Greenwich Mean Time |
|
|
|
● |
| Piper Sandler Healthcare Conference in New York, NY |
|
| Fireside chat on Tuesday, December 3 at 8:30 a.m. Eastern Time |
Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn and X (Twitter).
| Last Trade: | US$50.82 |
| Daily Change: | 1.28 2.58 |
| Daily Volume: | 2,050,227 |
| Market Cap: | US$6.300B |
June 03, 2025 May 27, 2025 | |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
